Eam Investors, LLC Reata Pharmaceuticals Inc Transaction History

Eam Investors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$126.3 - $176.56 $1.49 Million - $2.08 Million	-11,779 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$124.16 - $247.74 $68,412 - $136,504	551 Added 4.91%	11,779 $1.7 Million
Q4 2019 Feb 11, 2020	BUY	$74.57 - $217.92 $154,956 - $452,837	2,078 Added 22.71%	11,228 $2.3 Million
Q3 2019 Nov 13, 2019	SELL	$71.26 - $95.75 $1.41 Million - $1.89 Million	-19,783 Reduced 68.38%	9,150 $735,000
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $698,236 - $847,640	-8,984 Reduced 23.69%	28,933 $2.73 Million
Q1 2019 May 13, 2019	BUY	$51.9 - $101.79 $26,520 - $52,014	511 Added 1.37%	37,917 $3.24 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $76.44 $1.26 Million - $1.97 Million	-25,771 Reduced 40.79%	37,406 $2.1 Million
Q3 2018 Nov 08, 2018	BUY	$35.64 - $92.06 $2.25 Million - $5.82 Million	63,177 New	63,177 $5.17 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.